Personalis MapKure, Personalis Partner to Screen Patients for BRAF Inhibitor Trial Personalis plans to develop a companion diagnostic to MapKure's BRAF inhibitor, BGB-3245, once biomarkers have been identified in the study. Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month. Personalis to Broaden Liquid Biopsy Footprint With Minimal Residual Disease Testing Premium The company recently announced a deal with personalized ctDNA testing firm Natera and will now follow that with the launch of its own MRD product this year. Personalis Q4 Revenues up 11 Percent The genomics company reported revenues of $20.2 million for the quarter, driven by growth in its pharmaceutical services business and other non-VA customers. Natera, Personalis Team up for Cancer Treatment Monitoring, MRD Testing Under the non-exclusive deal, Natera will use matched tumor and normal exome sequencing data from Personalis to validate the design of its Signatera ctDNA assays. Jan 27, 2021 Personalis Prices $150M Public Stock Offering Jan 12, 2021 Personalis Projects 2020 Q4 Revenues Up 11 Percent Dec 23, 2020 Personalis Sees New Neoantigen Platform Driving Improved Immunotherapy Prediction Premium Dec 18, 2020 New Products Posted to GenomeWeb: Personalis, AutoGen, Celemics, More Nov 5, 2020 Personalis Q3 Revenues Up 16 Percent Aug 12, 2020 Personalis Prices $125M Public Stock Offering Aug 7, 2020 New Products Posted to GenomeWeb: Illumina, Adaptive Biotechnologies, Personalis, More Aug 6, 2020 Personalis Q2 Revenues Up 23 Percent Jul 17, 2020 People in the News: New Appointments at Personalis, Predictive Oncology, HalioDx Jun 10, 2020 Personalis Taps Berry Genomics to Facilitate Expansion in China Jun 2, 2020 Personalis, Sarepta Therapeutics Exploring Immune Response to Precision Genetic Therapeutics May 8, 2020 People in the News: Mostafa Ronaghi, Stephen Moore, Alex Aravanis, More May 7, 2020 Personalis Q1 Revenues Up 36 Percent Apr 24, 2020 Personalis Aims to Broaden Pharma Services With New Program Premium Apr 21, 2020 Indivumed, Personalis Partner to Enhance Cancer Genomics Database Mar 25, 2020 Personalis Q4 Revenues Grow 38 Percent, Full-Year Revenues Up 73 Percent Feb 11, 2020 Advaxis Taps Personalis for Biomarker Discovery in Lung Cancer Immunotherapy Program Nov 19, 2019 Personalis, Merck KGaA to Study Cancer Biomarkers Using Immunogenomics Platform Nov 15, 2019 Personalis Highlights Use Cases for NeXT Platform as Company Seeks Greater Adoption Premium Nov 15, 2019 New Products Posted to GenomeWeb: NuProbe, Personalis, CBR, More Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.